FIRM FIXED PRICE
BAYER HEALTHCARE PHARMACEUTICALS INC - RADIUM FOR CANCER TREATMENT
PIID: 36C25626N0126
Signed Date: Oct 1, 2025Effective Date: Oct 1, 2025End Date: Closed on Mar 31, 2026
Key Details
Description
RADIUM FOR CANCER TREATMENT
Contractor Information
Contractor: BAYER HEALTHCARE PHARMACEUTICALS INC
UEI: V1EVGCK7XES8
CAGE Code: 59463
Location: WHIPPANY, NJ
Similar Awards
EXPRESS REPORT: PHARMACEUTICAL PRIME VENDOR (PPV)FY2026 NOVEMBER
MCKESSON CORPORATION
$1.4B
EXPRESS REPORT: PHARMACEUTICAL PRIME VENDOR (PPV)FY2026 OCTOBER
MCKESSON CORPORATION
$1.2B
EXPRESS REPORT: PHARMACEUTICAL PRIME VENDOR (PPV)FY2026 DECEMBER
MCKESSON CORPORATION
$1.1B
EXPRESS REPORT: PHARMACEUTICAL PRIME VENDOR (PPV)FY2026 JANUARY
MCKESSON CORPORATION
$1.1B
LENALIDOMIDE FOR THE SALISBURY VAMC, CHARLOTTE HCC, AND KERNERSVILLE HCC.
EXELAN PHARMACEUTICALS INC
$5.1M
Stay Updated
Get notified about new opportunities matching your interests.